alendronate has been researched along with Coxarthrosis in 6 studies
alendronic acid : A 1,1-bis(phosphonic acid) that is methanebis(phosphonic acid) in which the two methylene hydrogens are replaced by hydroxy and 3-aminopropyl groups.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Alendronate treatment by standard dose for osteoporosis showed clinical efficacy for decreasing pain but failed to show preventive effects for structural progression of hip osteoarthritis." | 2.78 | Alendronate treatment for hip osteoarthritis: prospective randomized 2-year trial. ( Nishii, T; Shiomi, T; Sugano, N; Tamura, S; Yoshikawa, H, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (16.67) | 29.6817 |
| 2010's | 5 (83.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Yukizawa, Y | 2 |
| Inaba, Y | 3 |
| Kobayashi, N | 3 |
| Choe, H | 1 |
| Kubota, S | 2 |
| Saito, T | 3 |
| Nishii, T | 1 |
| Tamura, S | 1 |
| Shiomi, T | 1 |
| Yoshikawa, H | 1 |
| Sugano, N | 1 |
| Uchiyama, M | 1 |
| Ike, H | 1 |
| Tapaninen, TS | 1 |
| Venesmaa, PK | 1 |
| Jurvelin, JS | 1 |
| Miettinen, HJ | 1 |
| Kröger, HP | 1 |
| Iwamoto, N | 1 |
| Ishida, T | 1 |
| Mehlhorn, AT | 1 |
| Rechl, H | 1 |
| Gradinger, R | 1 |
| Stemberger, A | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| A Randomized Placebo Controlled Trial Testing The Effect of Zoledronic Acid on Hip Osteoarthritis[NCT04303026] | Phase 3 | 70 participants (Anticipated) | Interventional | 2020-03-02 | Recruiting | ||
| An Open-Label Phase 2 Study of Abaloparatide to Mitigate Distal Femoral Bone Loss Following Total Knee Arthroplasty[NCT04167163] | Phase 4 | 58 participants (Actual) | Interventional | 2020-01-10 | Active, not recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
6 trials available for alendronate and Coxarthrosis
| Article | Year |
|---|---|
Efficacy of Alendronate for the Prevention of Bone Loss in Calcar Region Following Total Hip Arthroplasty.
Topics: Absorptiometry, Photon; Adult; Aged; Aged, 80 and over; Alendronate; Arthroplasty, Replacement, Hip; | 2017 |
Alendronate treatment for hip osteoarthritis: prospective randomized 2-year trial.
Topics: Absorptiometry, Photon; Adult; Aged; Alendronate; Arthroplasty, Replacement, Hip; Bone Density; Bone | 2013 |
Teriparatide Versus Alendronate for the Preservation of Bone Mineral Density After Total Hip Arthroplasty - A randomized Controlled Trial.
Topics: Absorptiometry, Photon; Aged; Alendronate; Arthroplasty, Replacement, Hip; Body Mass Index; Bone Den | 2016 |
Alendronate reduces periprosthetic bone loss after uncemented primary total hip arthroplasty - a 5-year follow-up of 16 patients.
Topics: Aged; Alendronate; Arthroplasty, Replacement, Hip; Bone Density; Bone Density Conservation Agents; B | 2010 |
A comparison of the effects of alendronate and alfacalcidol on bone mineral density around the femoral implant and in the lumbar spine after total hip arthroplasty.
Topics: Aged; Alendronate; Arthroplasty, Replacement, Hip; Bone Density; Bone Density Conservation Agents; F | 2011 |
Alendronate decreases TRACP 5b activity in osteoarthritic bone.
Topics: Acid Phosphatase; Aged; Alendronate; Bone and Bones; Bone Density Conservation Agents; Cell Count; F | 2008 |